Immuron Limited (IMRN)
NASDAQ: IMRN · IEX Real-Time Price · USD
2.640
-0.080 (-2.94%)
At close: Jul 19, 2024, 4:00 PM
2.710
+0.070 (2.65%)
Pre-market: Jul 20, 2024, 9:27 AM EDT
Immuron Revenue
Immuron had revenue of $2.43M in the twelve months ending December 31, 2023. In the fiscal year ending June 30, 2023, Immuron had annual revenue of $1.24M with 134.22% growth.
Revenue (ttm)
$2.43M
Revenue Growth
+134.22%
P/S Ratio
6.18
Revenue / Employee
$405,515
Employees
6
Market Cap
15.05M USD
Revenue Chart
* The company reports in AUD currency but revenue data is shown in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2023 | 1.24M | 713.24K | 134.22% |
Jun 30, 2022 | 531.38K | 421.78K | 384.81% |
Jun 30, 2021 | 109.61K | -1.63M | -93.69% |
Jun 30, 2020 | 1.74M | 55.66K | 3.31% |
Jun 30, 2019 | 1.68M | 316.17K | 23.16% |
Jun 30, 2018 | 1.37M | 291.37K | 27.14% |
Jun 30, 2017 | 1.07M | 328.40K | 44.06% |
Jun 30, 2016 | 745.35K | -27.17K | -3.52% |
Jun 30, 2015 | 772.52K | -151.69K | -16.41% |
Jun 30, 2014 | 924.21K | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Flora Growth | 74.78M |
Centogene | 53.93M |
Star Equity Holdings | 42.56M |
BIMI International Medical | 5.85M |
Talis Biomedical | 989.00K |
Talphera | 651.00K |
IMRN News
- 20 days ago - Immuron requests pre-IND meeting for IMM-529 with FDA filing - GlobeNewsWire
- 6 weeks ago - Immuron CEO, Steven Lydeamore to present at the Emerging Growth Conference - GlobeNewsWire
- 7 weeks ago - Immuron Board Changes - GlobeNewsWire
- 7 weeks ago - Immuron CEO Steven Lydeamore to present at Peak Sky High - GlobeNewsWire
- 2 months ago - Immuron Limited to Present at the Emerging Growth Conference - GlobeNewsWire
- 2 months ago - Immuron Director Resignation - GlobeNewsWire
- 3 months ago - Immuron to host Live Virtual Event - GlobeNewsWire
- 3 months ago - Immuron Travelan® sales continued strong growth - GlobeNewsWire